2025-2031 Global iPSC Derived Cell Drugs Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Medical Care > 2025-2031 Global iPSC Derived Cell Drugs Industry Research & Trends Analysis Report

2025-2031 Global iPSC Derived Cell Drugs Industry Research & Trends Analysis Report

Publication Date: 2025-03-26
Report Id: 1996399
Industry: Medical Care
Report Page: 116
Chart: 122

PDF Download

Publication Date: 2025-03-26
Report Id: 1996399
Industry: Medical Care
Report Page: 116
Chart: 122

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of iPSC Derived Cell Drugs
1.2 Global iPSC Derived Cell Drugs Market Size and Forecast
1.3 China iPSC Derived Cell Drugs Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China iPSC Derived Cell Drugs Share in Global Market, 2020-2031
1.4.2 iPSC Derived Cell Drugs Market Size: China VS Global, 2020-2031
1.5 iPSC Derived Cell Drugs Market Dynamics
1.5.1 iPSC Derived Cell Drugs Market Drivers
1.5.2 iPSC Derived Cell Drugs Market Restraints
1.5.3 iPSC Derived Cell Drugs Industry Trends
1.5.4 iPSC Derived Cell Drugs Industry Policy

2 Competitive Landscape by Company
2.1 Global iPSC Derived Cell Drugs Revenue by Company, 2020-2025
2.2 Global iPSC Derived Cell Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global iPSC Derived Cell Drugs Concentration Ratio
2.4 Global iPSC Derived Cell Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global iPSC Derived Cell Drugs Manufacturers Product Type
2.6 Global Geographic Distribution of iPSC Derived Cell Drugs Companies

3 China Competitive Situation by Company
3.1 China iPSC Derived Cell Drugs Revenue by Company, 2020-2025
3.2 China iPSC Derived Cell Drugs iPSC Derived Cell Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China iPSC Derived Cell Drugs Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 iPSC Derived Cell Drugs Industry Chain
4.2 iPSC Derived Cell Drugs Upstream Analysis
4.3 iPSC Derived Cell Drugs Midstream Analysis
4.4 iPSC Derived Cell Drugs Downstream Analysis

5 Sights by Type
5.1 iPSC Derived Cell Drugs Classification
5.1.1 Autologous iPSC Derived Cell Drugs
5.1.2 Universal iPSC Derived Cell Drugs
5.2 by Type, Global iPSC Derived Cell Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global iPSC Derived Cell Drugs Market Size, 2020-2031

6 Sights by Application
6.1 iPSC Derived Cell Drugs Segment by Application
6.1.1 Anti-Inflammatory Repair
6.1.2 Tumor Immunity
6.1.3 Regenerative Medicine
6.1.4 Others
6.2 by Application, Global iPSC Derived Cell Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global iPSC Derived Cell Drugs Market Size, 2020-2031

7 Sights by Region
7.1 By Region, Global iPSC Derived Cell Drugs Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global iPSC Derived Cell Drugs Market Size, 2020-2031
7.3 North America
7.3.1 North America iPSC Derived Cell Drugs Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America iPSC Derived Cell Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe iPSC Derived Cell Drugs Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe iPSC Derived Cell Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific iPSC Derived Cell Drugs Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific iPSC Derived Cell Drugs Market Size Market Share
7.6 South America
7.6.1 South America iPSC Derived Cell Drugs Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America iPSC Derived Cell Drugs Market Size Market Share
7.7 Middle East & Africa

8 Sights by Country Level
8.1 By Country, Global iPSC Derived Cell Drugs Market Size & CAGR，2020 VS 2024 VS 2031
8.2 By Country, Global iPSC Derived Cell Drugs Market Size, 2020-2031
8.3 United States
8.3.1 United States iPSC Derived Cell Drugs Market Size, 2020-2031
8.3.2 By Company, United States iPSC Derived Cell Drugs Revenue Market Share, 2024
8.3.3 by Type, United States iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe iPSC Derived Cell Drugs Market Size, 2020-2031
8.4.2 By Company, Europe iPSC Derived Cell Drugs Revenue Market Share, 2024
8.4.3 by Type, Europe iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China iPSC Derived Cell Drugs Market Size, 2020-2031
8.5.2 By Company, China iPSC Derived Cell Drugs Revenue Market Share, 2024
8.5.3 by Type, China iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan iPSC Derived Cell Drugs Market Size, 2020-2031
8.6.2 By Company, Japan iPSC Derived Cell Drugs Revenue Market Share, 2024
8.6.3 by Type, Japan iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea iPSC Derived Cell Drugs Market Size, 2020-2031
8.7.2 By Company, South Korea iPSC Derived Cell Drugs Revenue Market Share, 2024
8.7.3 by Type, South Korea iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia iPSC Derived Cell Drugs Market Size, 2020-2031
8.8.2 By Company, Southeast Asia iPSC Derived Cell Drugs Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India iPSC Derived Cell Drugs Market Size, 2020-2031
8.9.2 By Company, India iPSC Derived Cell Drugs Revenue Market Share, 2024
8.9.3 by Type, India iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa iPSC Derived Cell Drugs Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa iPSC Derived Cell Drugs Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa iPSC Derived Cell Drugs Revenue Market Share, 2024 VS 2031

9 Company Profile
9.1 Shanghai UniXell Biotechnology
9.1.1 Shanghai UniXell Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.1.2 Shanghai UniXell Biotechnology Company Profile and Main Business
9.1.3 Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Models, Specifications, and Application
9.1.4 Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.1.5 Shanghai UniXell Biotechnology Recent Developments
9.2 HELP Therapeutics
9.2.1 HELP Therapeutics Company Information, Head Office, Market Area, and Industry Position
9.2.2 HELP Therapeutics Company Profile and Main Business
9.2.3 HELP Therapeutics iPSC Derived Cell Drugs Models, Specifications, and Application
9.2.4 HELP Therapeutics iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.2.5 HELP Therapeutics Recent Developments
9.3 Hopstem Biotechnology
9.3.1 Hopstem Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.3.2 Hopstem Biotechnology Company Profile and Main Business
9.3.3 Hopstem Biotechnology iPSC Derived Cell Drugs Models, Specifications, and Application
9.3.4 Hopstem Biotechnology iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.3.5 Hopstem Biotechnology Recent Developments
9.4 Nuwacell
9.4.1 Nuwacell Company Information, Head Office, Market Area, and Industry Position
9.4.2 Nuwacell Company Profile and Main Business
9.4.3 Nuwacell iPSC Derived Cell Drugs Models, Specifications, and Application
9.4.4 Nuwacell iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.4.5 Nuwacell Recent Developments
9.5 Allele Biotech
9.5.1 Allele Biotech Company Information, Head Office, Market Area, and Industry Position
9.5.2 Allele Biotech Company Profile and Main Business
9.5.3 Allele Biotech iPSC Derived Cell Drugs Models, Specifications, and Application
9.5.4 Allele Biotech iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.5.5 Allele Biotech Recent Developments
9.6 BlueRock Therapeutics
9.6.1 BlueRock Therapeutics Company Information, Head Office, Market Area, and Industry Position
9.6.2 BlueRock Therapeutics Company Profile and Main Business
9.6.3 BlueRock Therapeutics iPSC Derived Cell Drugs Models, Specifications, and Application
9.6.4 BlueRock Therapeutics iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.6.5 BlueRock Therapeutics Recent Developments
9.7 Century Therapeutics
9.7.1 Century Therapeutics Company Information, Head Office, Market Area, and Industry Position
9.7.2 Century Therapeutics Company Profile and Main Business
9.7.3 Century Therapeutics iPSC Derived Cell Drugs Models, Specifications, and Application
9.7.4 Century Therapeutics iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.7.5 Century Therapeutics Recent Developments
9.8 Fate Therapeutics
9.8.1 Fate Therapeutics Company Information, Head Office, Market Area, and Industry Position
9.8.2 Fate Therapeutics Company Profile and Main Business
9.8.3 Fate Therapeutics iPSC Derived Cell Drugs Models, Specifications, and Application
9.8.4 Fate Therapeutics iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.8.5 Fate Therapeutics Recent Developments
9.9 Cellino
9.9.1 Cellino Company Information, Head Office, Market Area, and Industry Position
9.9.2 Cellino Company Profile and Main Business
9.9.3 Cellino iPSC Derived Cell Drugs Models, Specifications, and Application
9.9.4 Cellino iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.9.5 Cellino Recent Developments
9.10 Xellsmart
9.10.1 Xellsmart Company Information, Head Office, Market Area, and Industry Position
9.10.2 Xellsmart Company Profile and Main Business
9.10.3 Xellsmart iPSC Derived Cell Drugs Models, Specifications, and Application
9.10.4 Xellsmart iPSC Derived Cell Drugs Revenue and Gross Margin, 2020-2025
9.10.5 Xellsmart Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for iPSC Derived Cell Drugs should grow from US$ 233 million in 2024 to US$ 315 million by 2031, with a CAGR of 5.2% for the period of 2025-2031.

iPSC-derived cell drugs are drugs prepared using induced pluripotent stem cell (iPSC) technology. iPSCs are obtained by introducing specific transcription factors into somatic cells to reprogram them into pluripotent stem cells. These pluripotent stem cells have the potential to differentiate into various cell types and can therefore be used to prepare cell drugs for the treatment of specific diseases. iPSC-derived cell drugs have broad application prospects in the treatment of degenerative diseases, tissue repair, and other areas. By directing the differentiation of iPSCs into specific types of cells, such as neurons and cardiomyocytes, personalized cell replacement therapies can be provided to patients, thereby restoring the function of damaged tissues.

iPSC Derived Cell Drugs

According to YH Research, the global market for iPSC Derived Cell Drugs should grow from US$ 233 million in 2024 to US$ 315 million by 2031, with a CAGR of 5.2% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

China iPSC Derived Cell Drugs market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

The United States iPSC Derived Cell Drugs market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

In terms of product type, Autologous iPSC Derived Cell Drugs segment holds a share about % in 2024, and will reach % in 2031; while in terms of end use, Anti-Inflammatory Repair has a share approximately % in 2024, and will grow at a CAGR % during 2025 and 2031.

The global key manufacturers of iPSC Derived Cell Drugs include Shanghai UniXell Biotechnology, HELP Therapeutics, Hopstem Biotechnology, Nuwacell, Allele Biotech, BlueRock Therapeutics, Century Therapeutics, Fate Therapeutics, Cellino, Xellsmart, etc. In 2024, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for iPSC Derived Cell Drugs. Report Highlights:
(1) Global iPSC Derived Cell Drugs market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global iPSC Derived Cell Drugs market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China iPSC Derived Cell Drugs market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global iPSC Derived Cell Drugs segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global iPSC Derived Cell Drugs segment by Type, and by Application, and regional segment by Type, and by Application.

(6) iPSC Derived Cell Drugs industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Autologous iPSC Derived Cell Drugs
    Universal iPSC Derived Cell Drugs

Market segment by Application, can be divided into
    Anti-Inflammatory Repair
    Tumor Immunity
    Regenerative Medicine
    Others

Market segment by players, this report covers
    Shanghai UniXell Biotechnology
    HELP Therapeutics
    Hopstem Biotechnology
    Nuwacell
    Allele Biotech
    BlueRock Therapeutics
    Century Therapeutics
    Fate Therapeutics
    Cellino
    Xellsmart